AnchorDx Medical Partners with DiaCarta for Global Molecular Diagnostics Development
AnchorDx Medical Co., Ltd, a specialist in methylation high-throughput sequencing based in China, has entered...
AnchorDx Medical
AnchorDx’s UriFind Receives Breakthrough Therapy Designation for Urothelial Carcinoma
China-based Guangzhou AnchorDx Medical Co., Ltd, a specialist in methylation high-throughput sequencing, has obtained a...
AnchorDx Initiates US Registrational Study for UriFind Urothelial Carcinoma Diagnostic
China-based AnchorDx Medical Co., Ltd, a specialist in methylation high-throughput sequencing, has announced the initiation...
AnchorDx and West China Hospital Collaborate on Lung Cancer Early Diagnosis
Guangzhou-based AnchorDx and West China Hospital of Sichuan University have entered into a transfer agreement...